An assembly of TROP2-mediated signaling events

Abhinand CS, Raju R, Soumya SJ, Arya PS, Sudhakaran PR (2016) VEGF-A/VEGFR2 signaling network in endothelial cells relevant to angiogenesis. J Cell Commun Signal 10(4):347–354

Article  PubMed  PubMed Central  Google Scholar 

Aravind A, Palollathil A, Rex DAB, Kumar KMK, Vijayakumar M, Shetty R, Codi JAK, Prasad TSK, Raju R (2022) A multi-cellular molecular signaling and functional network map of C-C motif chemokine ligand 18 (CCL18): a chemokine with immunosuppressive and pro-tumor functions. J Cell Commun Signal 16(2):293–300

Article  CAS  PubMed  Google Scholar 

Bardia A, Messersmith WA, Kio EA, Berlin JD, Vahdat L, Masters GA, Moroose R, Santin AD, Kalinsky K, Picozzi V, O’Shaughnessy J, Gray JE, Komiya T, Lang JM, Chang JC, Starodub A, Goldenberg DM, Sharkey RM, Maliakal P, Hong Q, Wegener WA, Goswami T, Ocean AJ (2021) Sacituzumab govitecan, a trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial. Ann Oncol 32(6):746–756

Article  CAS  PubMed  Google Scholar 

Calabrese G, Crescenzi C, Morizio E, Palka G, Guerra E, Alberti S (2001) Assignment of TACSTD1 (alias TROP1, M4S1) to human chromosome 2p21 and refinement of mapping of TACSTD2 (alias TROP2, M1S1) to human chromosome 1p32 by in situ hybridization. Cytogenet Cell Genet 92(1–2):164–165

Article  CAS  PubMed  Google Scholar 

Cubas R, Li M, Chen C, Yao Q (2009) TROP2: a possible therapeutic target for late stage epithelial carcinomas. Biochim Biophys Acta 1796(2):309–314

CAS  PubMed  Google Scholar 

Cubas R, Zhang S, Li M, Chen C, Yao Q (2010) TROP2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol Cancer 9:253

Article  PubMed  PubMed Central  Google Scholar 

Dagamajalu S, Rex DAB, Palollathil A, Shetty R, Bhat G, Cheung LWT, Prasad TSK (2021) Correction to: a pathway map of AXL receptor-mediated signaling network. J Cell Commun Signal 15(1):149

Article  CAS  PubMed  Google Scholar 

Fong D, Moser P, Krammel C, Gostner JM, Margreiter R, Mitterer M, Gastl G, Spizzo G (2008) High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br J Cancer 99(8):1290–1295

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goldenberg DM, Stein R, Sharkey RM (2018) The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target. Oncotarget 9(48):28989–29006

Article  PubMed  PubMed Central  Google Scholar 

Gu QZ, Nijiati A, Gao X, Tao KL, Li CD, Fan XP, Tian Z (2018) TROP2 promotes cell proliferation and migration in osteosarcoma through PI3K/AKT signaling. Mol Med Rep 18(2):1782–1788

CAS  PubMed  Google Scholar 

Guan H, Guo Z, Liang W, Li H, Wei G, Xu L, Xiao H, Li Y (2017) TROP2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways. BMC Cancer 17(1):486

Article  PubMed  PubMed Central  Google Scholar 

Guerra E, Trerotola M, Aloisi AL, Tripaldi R, Vacca G, La Sorda R, Lattanzio R, Piantelli M, Alberti S (2013) The trop-2 signalling network in cancer growth. Oncogene 32(12):1594–1600

Article  CAS  PubMed  Google Scholar 

Guerra E, Trerotola M, Tripaldi R, Aloisi AL, Simeone P, Sacchetti A, Relli V, D’Amore A, La Sorda R, Lattanzio R, Piantelli M, Alberti S (2016) Trop-2 induces tumor growth through AKT and determines sensitivity to AKT inhibitors. Clin Cancer Res 22(16):4197–4205

Article  CAS  PubMed  Google Scholar 

Guerra E, Trerotola M, Relli V, Lattanzio R, Tripaldi R, Vacca G, Ceci M, Boujnah K, Garbo V, Moschella A, Zappacosta R, Simeone P, de Lange R, Weidle UH, Rotelli MT, Picciariello A, Depalo R, Querzoli P, Pedriali M, Bianchini E, Angelucci D, Pizzicannella G, Di Loreto C, Piantelli M, Antolini L, Sun XF, Altomare DF, Alberti S (2021) Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer. Neoplasia 23(9):898–911

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo X, Zhu X, Zhao L, Li X, Cheng D, Feng K (2017) Tumor-associated calcium signal transducer 2 regulates neovascularization of non-small-cell lung cancer via activating ERK1/2 signaling pathway. Tumour Biol 39(3):1010428317694324

Article  PubMed  Google Scholar 

Hou J, Lv A, Deng Q, Zhang G, Hu X, Cui H (2019) TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway. Oncol Rep 41(2):753–764

CAS  PubMed  Google Scholar 

Howland JG, Wang YT (2008) Synaptic plasticity in learning and memory: stress effects in the hippocampus. Prog Brain Res 169:145–158

Article  CAS  PubMed  Google Scholar 

Hsu EC, Rice MA, Bermudez A, Marques FJG, Aslan M, Liu S, Ghoochani A, Zhang CA, Chen YS, Zlitni A, Kumar S, Nolley R, Habte F, Shen M, Koul K, Peehl DM, Zoubeidi A, Gambhir SS, Kunder CA, Pitteri SJ, Brooks JD, Stoyanova T (2020) TROP2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1. Proc Natl Acad Sci U S A 117(4):2032–2042

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jia L, Wang T, Ding G, Kuai X, Wang X, Wang B, Zhao W, Zhao Y (2020) TROP2 inhibition of P16 expression and the cell cycle promotes intracellular calcium release in OSCC. Int J Biol Macromol 164:2409–2417

Article  CAS  PubMed  Google Scholar 

Ju X, Jiao X, Ertel A, Casimiro MC, Di Sante G, Deng S, Li Z, Di Rocco A, Zhan T, Hawkins A, Stoyanova T, Ando S, Fatatis A, Lisanti MP, Gomella LG, Languino LR, Pestell RG (2016) v-Src oncogene induces TROP2 proteolytic activation via cyclin D1. Cancer Res 76(22):6723–6734

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kandasamy K, Mohan SS, Raju R, Keerthikumar S, Kumar GS, Venugopal AK, Telikicherla D, Navarro JD, Mathivanan S, Pecquet C, Gollapudi SK, Tattikota SG, Mohan S, Padhukasahasram H, Subbannayya Y, Goel R, Jacob HK, Zhong J, Sekhar R, Nanjappa V, Balakrishnan L, Subbaiah R, Ramachandra YL, Rahiman BA, Prasad TS, Lin JX, Houtman JC, Desiderio S, Renauld JC, Constantinescu SN, Ohara O, Hirano T, Kubo M, Singh S, Khatri P, Draghici S, Bader GD, Sander C, Leonard WJ, Pandey A (2010) NetPath: a public resource of curated signal transduction pathways. Genome Biol 11(1):R3

Article  PubMed  PubMed Central  Google Scholar 

Kuai X, Jia L, Yang T, Huang X, Zhao W, Zhang M, Chen Y, Zhu J, Feng Z, Tang Q (2020) TROP2 promotes multidrug resistance by regulating notch1 signaling pathway in gastric cancer cells. Med Sci Monit 26:e919566

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kushiyama S, Yashiro M, Yamamoto Y, Sera T, Sugimoto A, Nishimura S, Togano S, Kuroda K, Yoshii M, Tamura T, Toyokawa T, Tanaka H, Muguruma K, Nakada H, Ohira M (2021) Clinicopathologic significance of TROP2 and phospho-TROP2 in gastric cancer. Mol Clin Oncol 14(5):105

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kutmon M, van Iersel MP, Bohler A, Kelder T, Nunes N, Pico AR, Evelo CT (2015) PathVisio 3: an extendable pathway analysis toolbox. PLoS Comput Biol 11(2):e1004085

Article  PubMed  PubMed Central  Google Scholar 

Li X, Teng S, Zhang Y, Zhang W, Zhang X, Xu K, Yao H, Yao J, Wang H, Liang X, Hu Z (2017) TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT. Oncotarget 8(29):47052–47063

Article  PubMed  PubMed Central  Google Scholar 

Lin JC, Wu YY, Wu JY, Lin TC, Wu CT, Chang YL, Jou YS, Hong TM, Yang PC (2012) TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma. EMBO Mol Med 4(6):472–485

Article  CAS  PubMed  PubMed Central  Google Scholar 

Linnenbach AJ, Wojcierowski J, Wu SA, Pyrc JJ, Ross AH, Dietzschold B, Speicher D, Koprowski H (1989) Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733. Proc Natl Acad Sci U S A 86(1):27–31

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lipinski M, Parks DR, Rouse RV, Herzenberg LA (1981) Human trophoblast cell-surface antigens defined by monoclonal antibodies. Proc Natl Acad Sci U S A 78(8):5147–5150

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu T, Liu Y, Bao X, Tian J, Liu Y, Yang X (2013) Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway. PLoS ONE 8(9):e75864

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mori Y, Akita K, Ojima K, Iwamoto S, Yamashita T, Morii E, Nakada H (2019) Trophoblast cell surface antigen 2 (Trop-2) phosphorylation by protein kinase C alpha/delta (PKCalpha/delta) enhances cell motility. J Biol Chem 294(30):11513–11524

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mustata RC, Vasile G, Fernandez-Vallone V, Strollo S, Lefort A, Libert F, Monteyne D, Perez-Morga D, Vassart G, Garcia MI (2013) Identification of Lgr5-independent spheroid-generating progenitors of the mouse fetal intestinal epithelium. Cell Rep 5(2):421–432

Article  CAS  PubMed  Google Scholar 

Pavsic M (2021) TROP2 forms a stable dimer with significant structural differences within the membrane-distal region as compared to EpCAM. Int J Mol Sci 22(19):10640

Article  CAS  PubMed  PubMed Central 

留言 (0)

沒有登入
gif